H.C. Wainwright analyst Douglas Tsao reiterates a Buy rating on Argenx (ARGX) with a $617 price target after the company said it is advancing efgartigimod subcutaneous in all three subtypes of ...

Topline results from the MUSCLE study indicate that ulviprubart did not meet its primary endpoint of mean change in inclusion body myositis functional rating scale scores.

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Although new targets and therapies are on the horizon, current myositis treatment strategies rely ...

Please provide your email address to receive an email when new articles are posted on . Among patients with myositis, younger individuals with dermatomyositis are more likely to experience pain, while ...

The last time I spoke about Cartesian Therapeutics (RNAC) it was in a Seeking Alpha article entitled "Cartesian: Further Value To Be Unlocked After Positive MG Treatment Data." There, I wrote about ...

PHILADELPHIA, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for ...

(MENAFN- GetNews) (Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Myositis pipeline constitutes 18+ key companies continuously working towards developing 20+ Myositis ...

Argenx Se (ARGX) has released an update. Don't Miss our Black Friday Offers: Argenx SE is advancing the clinical development of its subcutaneous treatment, efgartigimod SC, for idiopathic inflammatory ...

PHILADELPHIA, May 16, 2023 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies ...

NEWTON, Mass.--(BUSINESS WIRE)--Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T ...

Dermatomyositis is a rare autoimmune disease that typically affects the skin, muscle and respiratory system. Patients with dermatomyositis usually require prompt treatment with intense ...